Concepedia

Sarah Whitmire

SW

Statistics

Publications

7

Citations

279

H-Index

7

Active since

2016

Affiliations

Novo Nordisk (United States)(Current)

Sarah Whitmire is an author at Novo Nordisk (United States) specializing in medicine, health services research, and spinal muscular atrophy.

ORCID

Publications per year

2016–2024

7

Publications

7

Effects of short indels on protein structure and function in human genomes

Maoxuan Lin, Sarah Whitmire, Jing Chen et al. · Scientific Reports · 2017 · 103 citations · Full text

, , +11

Semaglutide Once-Weekly Persistence and Adherence Versus Other GLP-1 RAs in Patients with Type 2 Diabetes in a US Real-World Setting

Chioma Uzoigwe, Yuanjie Liang, Sarah Whitmire et al. · Diabetes Therapy · 2021 · 59 citations · Full text

, , +17

The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation

Weiguo Dong, Christine M. Embury, Yaman Lu et al. · Journal of Neuroinflammation · 2016 · 28 citations · Full text

, , +17

Impact of medications on salivary flow rate in patients with xerostomia: a retrospective study by the Xeromeds Consortium

Giulio Fortuna, Sarah Whitmire, Kathleen Sullivan et al. · Clinical Oral Investigations · 2022 · 27 citations · Full text

, , +15

Newborn Screening and Birth Prevalence for Spinal Muscular Atrophy in the US

Lisa Belter, Jennifer Taylor, Erica Jorgensen et al. · JAMA Pediatrics · 2024 · 27 citations · Full text

, , +16

1–5 of 7